SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

11317	Companies
251455	Keywords
180564	Articles
137279	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/09/2025 at 07:00, 1 year 5 months ago

Communiqué de presse : Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de VRS
Sanofi accélère la livraison mondiale de Beyfortus pour anticiper la saison 2025-2026 de VRS. Durée de protection prolongée à six mois dans l'UE. Beyfortus : protection contre le VRS chez les nourrissons

Sanofi VRS Beyfortus Nourrissons Protection
PRESS RELEASE

published on 06/09/2025 at 07:00, 1 year 5 months ago

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season, ensuring broad availability and high efficacy for infants

Healthcare Sanofi Vaccine RSV Beyfortus
BRIEF

published on 06/06/2025 at 20:27, 1 year 5 months ago

Sanofi Discloses Repurchase of Own Shares in Early June 2025

Share Repurchase XPAR Market Stock Transaction 2025 Sanofi
BRIEF

published on 06/06/2025 at 20:27, 1 year 5 months ago

Sanofi annonce un rachat d'actions propres début juin 2025

Rachat D'actions Marché XPAR 2025 Sanofi Transaction Sur Actions
PRESS RELEASE

published on 06/06/2025 at 20:22, 1 year 5 months ago

Sanofi: Disclosure of trading in own shares
Sanofi discloses its trading in own shares from 02 June 2025 to 06 June 2025, repurchasing a total of 105,316 shares at an average price of 86.91 EUR per share on XPAR market

Trading Own Shares XPAR Repurchases Sanofi
PRESS RELEASE

published on 06/06/2025 at 20:22, 1 year 5 months ago

Sanofi : Déclaration des transactions sur actions propres
Sanofi déclare les transactions sur actions propres du 02 Juin 2025 au 06 Juin 2025 conformément à la réglementation. Présentation agrégée par jour et par marché

Actions Propres Transactions Réglementation Sanofi Présentation Agrégée
BRIEF

published on 06/02/2025 at 07:05, 1 year 5 months ago

Sanofi to Acquire Blueprint Medicines for $9.5 Billion

Rare Diseases Sanofi Acquisition Blueprint Medicines Immunology Pipeline Systemic Mastocytosis
BRIEF

published on 06/02/2025 at 07:05, 1 year 5 months ago

Sanofi va acquérir Blueprint Medicines pour 9,5 milliards de dollars

Maladies Rares Acquisition De Sanofi Médicaments Blueprint Pipeline D'immunologie Mastocytose Systémique
PRESS RELEASE

published on 06/02/2025 at 07:00, 1 year 5 months ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 1 year 5 months ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1

Accesswire

Published on 11/11/2026 at 03:30, 5 hours 18 minutes ago

CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 8 hours 8 minutes ago

Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 9 hours 18 minutes ago

CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 9 hours 48 minutes ago

Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 9 hours 48 minutes ago

Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary

View all ACCESSWIRE

EQS Group

Published on 11/11/2026 at 08:31, 17 minutes ago

Delivery Hero SE: Notice to the Bondholders of the EUR 500 million Convertible Bonds due 2029 (ISIN DE000A3MP437 – Common Code 238511097 – German Securities Code (WKN) A3MP43)
Published on 11/11/2026 at 08:30, 17 minutes ago

Delivery Hero SE: Notice to the Bondholders of the EUR 1,000 million Convertible Bonds due 2030 (ISIN DE000A30V5R1 – Common Code 258943848 – German Securities Code (WKN) A30V5R)
Published on 11/11/2026 at 08:30, 18 minutes ago

Delivery Hero SE: Notice to the Bondholders of the EUR 750 million Convertible Bonds due 2028 (ISIN DE000A3H2WQ0 – Common Code 220637387 – German Securities Code (WKN) A3H2WQ)
Published on 11/11/2026 at 08:30, 18 minutes ago

aap Implantate AG: Management Board refines 2026 forecast and provides first outlook for 2027 – Ambition 2030: Revenue of at least EUR 21 million with an EBITDA margin of 17.5% to 22.5%
Published on 11/11/2026 at 08:30, 18 minutes ago

Delivery Hero SE: Notice to the Bondholders of the EUR 875 million Convertible Bonds due 2027 (ISIN DE000A254Y92 – Common Code 210751831 – German Securities Code (WKN) A254Y9)

Les Echos

Published on 11/10/2026 at 18:00, 14 hours 48 minutes ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 15 hours 3 minutes ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 15 hours 8 minutes ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 15 hours 13 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 15 hours 16 minutes ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE